Author

Dongxu Li

University of North Carolina at Chapel HillORCID 0000-0002-9701-5377Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Dongxu Li3 papers · Changping Laboratory

Biology Disciplines

Click to filter author papers

Synthetic Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:ChIP-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Brian P. HardyiD· 1 shared Bryce HartiD· 1 shared Cari A. SagumiD· 1 shared Carina PribitzeriD· 1 shared Catherine A. MusselmaniD· 1 shared Daniel BstehiD· 1 shared Dmitri KireeviD· 1 shared Gang Greg WangiD· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSynthetic Biology

Brian P. HardyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

REPROGRAMMING CBX8-PRC1 FUNCTION WITH A POSITIVE ALLOSTERIC MODULATOR

Junghyun L. Suh, Daniel Bsteh, Bryce Hart, Yibo Si, Tyler Weaver, Carina Pribitzer, Roy Lau, Shivani Soni, Heather Anne N. Ogana, Justin M. Rectenwald, Jacqueline L. Norris, Stephanie H. Cholensky, Cari A. Sagum, Jessica M. Umana, Dongxu Li, , Oliver Bell

This paper identifies UNC7040 as a potent CBX8-specific positive allosteric modulator that disrupts PRC1 function and reduces cancer cell proliferation.

Cell chemical biology · Oct 28, 2021Peer-reviewedSynthetic Biology